Skip to main content
Premium Trial:

Request an Annual Quote

Timeline of Events Leading to Tuschl IP Litigation

Premium

This week, Alnylam Pharmaceuticals launched its latest attack in an intellectual property lawsuit filed against the Whitehead Institute for Biomedical Research, the University of Massachusetts, and the Massachusetts Institute of Technology, questioning UMass' claim to ownership of certain IP at the heart of the dispute (see related story, this issue).

Although the suit was first filed last summer, the courtroom showdown had been brewing for years. Below is a snapshot of key events that led to the litigation.

chart1.jpgchart2_0.jpg

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.